Allergy Diagnostics Market is Projected to Grow Expeditiously: to Reach $11.54 Billion by 2029

 This report provides practical insights for business leaders looking to understand market growth, size, and key trends in the allergy diagnostics industry.

 

 How Much Is The Allergy Diagnostics Market Worth?
 The allergy diagnostics market size has grown rapidly in recent years. It will grow from $6.32 billion in 2024 to $6.99 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to rise in prevalence of allergies, investments in research and development of allergy diagnostics, changing dietary habits and environmental factors, government initiatives, rise in demand for personalized medicine.
 
 The allergy diagnostics market size is expected to see rapid growth in the next few years. It will grow to $11.54 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to economic growth, expanding healthcare infrastructure, expansion ofThe aging population, greater emphasis on early diagnosis and prevention,. Major trends in the forecast period include molecular allergy diagnostics, customized allergen profiles, allergy testing kits for home use, integration of artificial intelligence (AI), telemedicine and remote allergy consultations.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=5655&type=smp
 
 What Are The Current Leading Growth Drivers For Allergy Diagnostics Market?
 The increased occurrences of allergic diseases will propel the growth of the allergy diagnostics market. The rise in allergy diseases has been attributed to increased environmental pollution from traffic and numerous industries. An allergic reaction is described as an abnormal immune system response to an allergen. Allergy diseases include anaphylaxis, allergic rhinitis (often referred to as ‘hay fever’), food allergies, skin allergies, and allergic asthma. Avoiding the allergen is the most essential treatment for allergic disorders. As a result, proper allergy diagnosis is crucial for effective allergy treatment. For instance, according to the American College of Allergy, Asthma, and Immunology (ACAAI), asthma and allergic diseases were common in the US for all the age groups. Asthma affected 24 million people in the US which included more than 6 million children. Allergies were 6th leading cause of illness and costed around $18 million in excess. More than 50 million Americans suffered from allergies each year. Thus, the rise in the prevalence of allergic diseases will further support the growth of the allergic diagnostics market.
 
 Which Segment Accounted For The Largest Allergy Diagnostics Market Share?
 The allergy diagnosticsmarket covered in this report is segmented — 
 
 1) By Test Type: In-vivo Allergy Tests; In-vitro Allergy Tests 
 2) By Allergen: Inhaled Allergens; Food Allergens; Drug Allergens 
 3) By Products: Consumables; Instruments; Luminometers 
 4) By End User: Diagnostics Laboratories; Hospital-based Laboratories; Academic and Research Institutes
 
 Subsegments:
 1) By In-vivo Allergy Tests: Skin Prick Tests; Intradermal Tests; Patch Tests; Oral Food Challenge Tests 
 2) By In-vitro Allergy Tests: Enzyme-Linked Immunosorbent Assay (ELISA); Radioallergosorbent Test (RAST); Component-Resolved Diagnostics (CRD); Basophil Activation Tests (BAT) 
 
 Allergy Diagnostics Market Emerging Trends And Opportunities
 The rise in the number of collaborations and partnerships among companies operating in the allergy diagnostics industry to invent new testing methods or improve existing ones is a recent trend in the market. For instance, in August 2022, LifeMD, a US-based telehealth company announced strategic partnership between its wholly-owned subsidiary, Cleared and Allergenis, a US-based predictive data analytics company. The strategic partnership is aimed at leveraging Cleared’s allergy telehealth expertise and allergenis’ peanut allergy diagnostic blood test in the direct-to-customer channel.
 
 Which Are The Top Companies To Hold The Market Share In Allergy Diagnostics Market?
 Major companies operating in the allergy diagnostics market include BioMerieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC., Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Alcon Laboratories Inc., Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Astra Biotech GmbH, Stallergenes Greer, Diagenics Limited, DST Diagnostische Systeme & Technologien GmbH, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Microtest Laboratories Inc., Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Symbiotix Biotherapies Inc., Eurofins Viracor Inc., VRL Laboratories 
 
 View the full allergy diagnostics market report here:
 https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report
 
 Which Region Is Projected To Account For The Largest Share Of The Allergy Diagnostics Market?
 North America was the largest region in the allergy diagnostics market in 2024. The regions covered in the allergy diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company